Stay updated on MGCD516 Study in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the MGCD516 Study in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MGCD516 Study in Advanced Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown and the funding-lapse notice, along with Revision: v3.4.1, has been removed; these updates do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:39:41.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and NIH Clinical Center operations; updated the page revision to Revision: v3.4.1, replacing Revision: v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-03T23:42:56.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Minor UI and wording updates were made: a 'Show glossary' option was added, and the labels around updates and FEAR Act data were revised (e.g., introducing 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), with older forms removed and a new 'Revision: v3.4.0' tag introduced. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T23:42:14.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. This is a minor technical update and does not alter study details, eligibility criteria, locations, or contact information.
    Difference
    0.0%
    Check dated 2026-01-14T00:32:06.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing trial sites across numerous states (e.g., Alabama, California, Colorado, Florida, Illinois, Louisiana, Maryland, Massachusetts, Michigan, Missouri, Nebraska, New Mexico, New York, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin). Removed the HHS Vulnerability Disclosure and the prior v3.3.2 location listings.
    Difference
    2%
    Check dated 2025-12-23T08:13:30.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 from v3.3.1; there are no visible changes to study content, sections, or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:26:23.000Z thumbnail image

Stay in the know with updates to MGCD516 Study in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MGCD516 Study in Advanced Cancer Clinical Trial page.